BIOTECH'S INFLUENCE ON CURES!
ROCHE'S DISCOVERY : CERA"Results demonstrated a dose-dependent hemoglobin after 6 weeks of approximately 60% of patients had a dose response. HB levels maintained or improved during the 12 week period." An anti-anemia drug that would compete with Amgen Inc.'s anemia treatment Aranesp -- is slated for launch in 2012, and it will have at least five others on the market by 2017, Merck | RNA DISCOVERY: RNA ROCKS!
|